Similar Posts
The Silent, Terrible Toll of Sexual Harassment in Medical Schools
ByadminIt is hard for any physician to advance as a medical researcher. Competition for research funding is fierce; the rigors of publishing in prestigious medical journals are gargantuan. And women pursuing such careers face even bigger challenges, with many having to take on disproportionate burdens at home compared to their male colleagues (caring for kids,…
The Biggest Problem with Obamacare? People Didn’t Know What the Law Accomplished!
ByadminObamacare dramatically reduced the number of people in United States who lack health insurance. Reduced as in: brought the proportion down to historical lows. Yet very few Americans knew this about the law, which is part of the reason why so many people didn’t like Obamacare. Here’s evidence to back up that connection, from the…
How Doctors Turn Patients into Lobbyists
ByadminI recently spoke with a Washington Post reporter about a troubling practice. Physicians convince their patients to sign letters to influence public policies the patients often don’t understand. Here is the beginning of that piece. Check it out: A proposal to sharply cut a drug discount program that many hospitals rely on drew some 1,400…
Specialty Drugs at Especially High Prices
ByadminThere have been many wonderful new medications in the past decade or so, drugs that finally bring hope for many people with serious illnesses like rheumatoid arthritis, multiple sclerosis and even some advanced cancers. But these drugs often come at a high price. Here is a snapshot of drug spending in 2014, courtesy of the…
The Most Uninformative Holiday Family Newsletter Ever
ByadminTired of all those family newsletters that inundate you with overwhelming detail on all the amazing accomplishments of your friends’ children? I thought I would address that issue, in my latest edition of my own family newsletter. Hope you enjoy: Ubel/Greeno Annual Holiday Letter.
Cost of Treating Hepatitis C Is Soaring
ByadminHere is a fascinating picture from the Wall Street Journal, showing how much Medicare has been spending on hepatitis C treatments lately. You can see that the cost is rising dramatically: Keep in mind, however, that the new and expensive hepatitis C treatments currently on the market will dramatically reduce costs in the future, because…